Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

209 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Does anxiety moderate the effectiveness of mirtazapine in patients with treatment-resistant depression? A secondary analysis of the MIR trial.
Rifkin-Zybutz R, MacNeill S, Davies SJ, Dickens C, Campbell J, Anderson IM, Chew-Graham CA, Peters TJ, Lewis G, Wiles N, Kessler D. Rifkin-Zybutz R, et al. Among authors: anderson im. J Psychopharmacol. 2020 Dec;34(12):1342-1349. doi: 10.1177/0269881120965939. Epub 2020 Nov 4. J Psychopharmacol. 2020. PMID: 33143538 Free PMC article. Clinical Trial.
Neuronal effects of acute citalopram detected by pharmacoMRI.
McKie S, Del-Ben C, Elliott R, Williams S, del Vai N, Anderson I, Deakin JF. McKie S, et al. Psychopharmacology (Berl). 2005 Aug;180(4):680-6. doi: 10.1007/s00213-005-2270-y. Epub 2005 May 12. Psychopharmacology (Berl). 2005. PMID: 15889241 Clinical Trial.
Development and validation of the Generalized Anxiety Disorder Inventory (GADI).
Argyropoulos SV, Ploubidis GB, Wright TS, Palm ME, Hood SD, Nash JR, Taylor AC, Forshall SW, Anderson IM, Nutt DJ, Potokar JP. Argyropoulos SV, et al. Among authors: anderson im. J Psychopharmacol. 2007 Mar;21(2):145-52. doi: 10.1177/0269881107069944. J Psychopharmacol. 2007. PMID: 17329293
Evidence-based pharmacological treatment of anxiety disorders, post-traumatic stress disorder and obsessive-compulsive disorder: a revision of the 2005 guidelines from the British Association for Psychopharmacology.
Baldwin DS, Anderson IM, Nutt DJ, Allgulander C, Bandelow B, den Boer JA, Christmas DM, Davies S, Fineberg N, Lidbetter N, Malizia A, McCrone P, Nabarro D, O'Neill C, Scott J, van der Wee N, Wittchen HU. Baldwin DS, et al. Among authors: anderson im. J Psychopharmacol. 2014 May;28(5):403-39. doi: 10.1177/0269881114525674. Epub 2014 Apr 8. J Psychopharmacol. 2014. PMID: 24713617 Free article.
Evidence-based guidelines for treating depressive disorders with antidepressants: A revision of the 2008 British Association for Psychopharmacology guidelines.
Cleare A, Pariante CM, Young AH, Anderson IM, Christmas D, Cowen PJ, Dickens C, Ferrier IN, Geddes J, Gilbody S, Haddad PM, Katona C, Lewis G, Malizia A, McAllister-Williams RH, Ramchandani P, Scott J, Taylor D, Uher R; Members of the Consensus Meeting. Cleare A, et al. Among authors: anderson im. J Psychopharmacol. 2015 May;29(5):459-525. doi: 10.1177/0269881115581093. Epub 2015 May 12. J Psychopharmacol. 2015. PMID: 25969470
209 results